Feature Channels: Addiction

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

A minority of people who use illicit opioids indicated a preference for fentanyl, the super-potent synthetic opioid that accounts for much of the recent rise in U.S. overdose deaths, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

• share
• favorite_border

• share
• favorite_border

A potential carcinogen that has been banned as a food additive is present in concerningly high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study from Duke Health.

• share
• favorite_border

• share
• favorite_border

Vivek H. Murthy, MD, MBA, the 19th U.S. Surgeon General and previous Vice Admiral of the U.S. Public Health Service Commissioned Corps, will join the Johns Hopkins Bloomberg School of Public Health as the Distinguished Policy Scholar, beginning in September 2019.

• share
• favorite_border

One out of every five tweets mentioning JUUL indentified for a new analysis also references addiction-related themes.

• share
• favorite_border

The Rutgers School of Public Health is excited to announce that Ollie Ganz, DrPH, MSPH, will be joining the department of health behavior, society, and policy as an instructor in November.

• share
• favorite_border

The American Thoracic Society applauds Michigan Governor Gretchen Whitmer’s decision to ban the sale of all flavored e-cigarette and vaping products in the state of Michigan.

• share
• favorite_border

Now that cannabis has been legalized for recreational use in Canada, there's a growing need for research exploring the mental health implications of increased access to cannabis. That's the focus of the September Special Issue of the Canadian Journal of Addiction, official publication of the Canadian Society of Addiction Medicine. The journal is published in the Lippincott portfolio by Wolters Kluwer.

• share
• favorite_border

Bisexual women had higher rates of past-year and daily marijuana use compared to heterosexual women, according to a study just published at Columbia University Mailman School of Public Health.

• share
• favorite_border

A group of private donors has given $17 million to start the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine, making it what’s believed to be the first such research center in the U.S., and the largest research center of its kind in the world.

• share
• favorite_border

The pending deal for Altria to purchase 35% of Juul Labs should serve as a “wake-up call” for the careful monitoring of competition in the nicotine delivery market, and for evaluating how regulations and policies impact cigarette and non-cigarette firms selling alternative nicotine delivery products, says a Georgetown University professor.

• share
• favorite_border

People who suffered a financial, housing-related, or job-related hardship as a result of the Great Recession were more likely to show increases in symptoms of depression

• share
• favorite_border

CBT is a counseling approach that addresses how people’s thoughts, feelings and behaviors influence each other in both healthy and harmful ways. It is already proven to be an effective treatment for alcohol use disorder, but has not been widely studied for an effect on DUI.

• share
• favorite_border

Alcohol biosensors suitable for use by everyday drinkers are a step closer, following a positive study of prototype devices published in the journal Alcoholism: Clinical & Experimental Research. Keeping track of alcohol intake can be challenging, given variation in standard drink sizes and impaired awareness as blood alcohol levels rise. Discreet devices that track alcohol levels could help people make more informed decisions about when to stop drinking and could potentially reduce alcohol-related road deaths.

• share
• favorite_border

• share
• favorite_border

An Oklahoma judge ordered Johnson & Johnson to pay $572 million for its role in the opioid crisis in a historic ruling Aug. 26. A federal case in Ohio involves at least 1,600  lawsuits from cities and counties throughout the country. Oxycontin maker Purdue Pharma has offered to settle more than 2,000 lawsuits from states and cities for between $10 billion and $12 billion.